Brief: Forward Pharma intends to appeal decision in patent interference proceeding with Biogen
31/03/2017 23:59
March 31 (Reuters) - Forward Pharma A/S FWP.O
* Forward Pharma intends to appeal decision in patent
interference proceeding with Biogen Inc.
Source text for Eikon: ID:nGNXNSGKAa
Further company coverage: FWP.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Forward Pharma A/S
See all newsBrief: Forward Pharma- Announces Termination Of Its American Depositary Receipts Facility
U.S. STOCKS ON THE MOVE-Madrigal, Disney, Forward Pharma
Forward Pharma slides to record low on delisting notice from Nasdaq
Brief: Forward Pharma Announces Delisting Its American Depositary Shares From Nasdaq Capital Market
Brief: Forward Pharma A/S Submitted A Request For A Written Decision Regarding Petition For Review Regarding EP2801355 To The EBA